• Shopping Cart Shopping Cart
    0Shopping Cart
XL-protein offers PASylation, a biological alternative to PEGylation
  • About
    • Corporate overview
    • Leadership team
  • Technology
    • Overview
    • Applications
      • Eye diseases
      • Cytokines
      • Enzymes
      • Peptides
      • Antibody fragments
      • Nanoparticles
      • In vivo imaging
      • AnimalHealth
    • PAS-Advantages
    • Intellectual property
  • Partnering
    • Partnering
  • News & Publications
    • Press Releases
    • Receive our Press Releases
    • Partner’s Press Releases
    • Key publications
    • Various publications
  • Careers
  • Contact
    • Contact
    • Imprint
    • Disclaimer
  • PAS-Shop
    • Products
    • Terms & Conditions
    • Privacy Policy
    • Shipping
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

10. June 2025
Read more
https://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.png 0 0 XL-protein https://xl-protein.com/wordpress/wp-content/uploads/2021/02/XLplogo3.png XL-protein2025-06-10 11:00:002025-06-10 11:20:12XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

Latest News:

  • XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology 10. June 2025
  • Akari Therapeutics Announces Pre-Clinical Development Progress Toward Potential IND on Long-Acting PAS-Nomacopan for Geographic Atrophy (GA) 15. February 2023
  • Bavarian Research Foundation supports the development of an immunosuppressive PASylated antibody fragment to support cardiac xenotransplantation 28. September 2022

Archives

  • June 2025
  • February 2023
  • September 2022
  • July 2022
  • October 2021
  • July 2021
  • February 2021
  • October 2020
  • February 2020
  • January 2020
  • April 2019
  • December 2018
  • January 2018
  • November 2017
  • July 2017
  • November 2016
  • June 2016
  • February 2016
  • December 2015
  • June 2015
  • February 2015
  • October 2014
  • August 2013
  • June 2013
  • April 2013
  • October 2012
  • June 2012
  • September 2011
  • March 2011
  • January 2011
  • September 2009

Partnering contact:

XL-protein GmbH
Uli Binder
Lise-Meitner-Str. 30
85354 Freising
Germany

Phone: +49 (0) 8161 53730-90
Fax: +49 (0) 8161 53730-99
E-mail: bd@xl-protein.com

Web: www.xl-protein.com

© 2024 - All Rights Reserved for XL-protein GmbH | Imprint | Disclaimer | Data Privacy Policy | Terms & Conditions
  • Link to Mail
Scroll to top Scroll to top Scroll to top